FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092487127> ?p ?o ?g. }

• W2092487127 endingPage "500" @default.
• W2092487127 startingPage "491" @default.
• W2092487127 abstract "Objectives Among elderly patients, mental and physical illness are often present along with alcohol dependence. The interaction between alcohol use and concurrent physical or mental disabilities is complex and complicates treatment planning. The aim of this study was to test the efficacy of naltrexone combined with sertraline for the treatment of older adults with major depression and alcohol dependence. Methods The sample was 74 subjects, age 55 and older, who met criteria for a depressive disorder along with alcohol dependence. All subjects were randomly assigned to 12 weeks of naltrexone 50 mg/day or placebo. Also, all subjects received sertraline 100 mg/day and individual weekly psychosocial support. Treatment response for alcohol consumption and depression was measured during the 12 weeks of treatment. Results At baseline, the average age of subjects was 63.4, and subjects were drinking an average of 10.7 drinks per drinking day. The overall results are encouraging; 42% of the subjects had a remission of their depression and had no drinking relapses during the trial. There was no evidence for an added benefit of naltrexone in combination with sertraline, but there was significant correlation between any alcohol relapse during the trial and poor response to depression treatment. Conclusions Patients with concurrent mental disorders, such as major depression and alcohol dependence, are increasingly prevalent in clinical practice and have been demonstrated to show poorer treatment response and higher treatment costs. The results of this trial underscore the importance of addressing alcohol use in the context of treating late-life depression. Among elderly patients, mental and physical illness are often present along with alcohol dependence. The interaction between alcohol use and concurrent physical or mental disabilities is complex and complicates treatment planning. The aim of this study was to test the efficacy of naltrexone combined with sertraline for the treatment of older adults with major depression and alcohol dependence. The sample was 74 subjects, age 55 and older, who met criteria for a depressive disorder along with alcohol dependence. All subjects were randomly assigned to 12 weeks of naltrexone 50 mg/day or placebo. Also, all subjects received sertraline 100 mg/day and individual weekly psychosocial support. Treatment response for alcohol consumption and depression was measured during the 12 weeks of treatment. At baseline, the average age of subjects was 63.4, and subjects were drinking an average of 10.7 drinks per drinking day. The overall results are encouraging; 42% of the subjects had a remission of their depression and had no drinking relapses during the trial. There was no evidence for an added benefit of naltrexone in combination with sertraline, but there was significant correlation between any alcohol relapse during the trial and poor response to depression treatment. Patients with concurrent mental disorders, such as major depression and alcohol dependence, are increasingly prevalent in clinical practice and have been demonstrated to show poorer treatment response and higher treatment costs. The results of this trial underscore the importance of addressing alcohol use in the context of treating late-life depression." @default.
• W2092487127 created "2016-06-24" @default.
• W2092487127 creator A5067161403 @default.
• W2092487127 date "2005-06-01" @default.
• W2092487127 modified "2023-09-26" @default.
• W2092487127 title "Treatment of Late-Life Depression Complicated by Alcohol Dependence" @default.
• W2092487127 cites W1551918730 @default.
• W2092487127 cites W1709742262 @default.
• W2092487127 cites W1847168837 @default.
• W2092487127 cites W1965804253 @default.
• W2092487127 cites W1973469222 @default.
• W2092487127 cites W1985792649 @default.
• W2092487127 cites W1987660334 @default.
• W2092487127 cites W2000271068 @default.
• W2092487127 cites W2006897648 @default.
• W2092487127 cites W2011177501 @default.
• W2092487127 cites W2013411432 @default.
• W2092487127 cites W2019860424 @default.
• W2092487127 cites W2020045114 @default.
• W2092487127 cites W2024374498 @default.
• W2092487127 cites W2024785470 @default.
• W2092487127 cites W2027131933 @default.
• W2092487127 cites W2030038103 @default.
• W2092487127 cites W2036259797 @default.
• W2092487127 cites W2042217830 @default.
• W2092487127 cites W2048324588 @default.
• W2092487127 cites W2050482992 @default.
• W2092487127 cites W2060034279 @default.
• W2092487127 cites W2065478102 @default.
• W2092487127 cites W2069073669 @default.
• W2092487127 cites W2074406420 @default.
• W2092487127 cites W2074912749 @default.
• W2092487127 cites W2093559862 @default.
• W2092487127 cites W2093607147 @default.
• W2092487127 cites W2095860751 @default.
• W2092487127 cites W2104538950 @default.
• W2092487127 cites W2107970821 @default.
• W2092487127 cites W2114613490 @default.
• W2092487127 cites W2115610172 @default.
• W2092487127 cites W2121477985 @default.
• W2092487127 cites W2122311243 @default.
• W2092487127 cites W2123541219 @default.
• W2092487127 cites W2145778815 @default.
• W2092487127 cites W2154717186 @default.
• W2092487127 cites W2159474490 @default.
• W2092487127 cites W2162337181 @default.
• W2092487127 cites W2168373111 @default.
• W2092487127 cites W2168630533 @default.
• W2092487127 cites W2252948336 @default.
• W2092487127 cites W2885386535 @default.
• W2092487127 cites W4231642013 @default.
• W2092487127 cites W4232533678 @default.
• W2092487127 cites W4241374261 @default.
• W2092487127 cites W4243813175 @default.
• W2092487127 doi "https://doi.org/10.1097/00019442-200506000-00008" @default.
• W2092487127 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3172720" @default.
• W2092487127 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15956269" @default.
• W2092487127 hasPublicationYear "2005" @default.
• W2092487127 type Work @default.
• W2092487127 sameAs 2092487127 @default.
• W2092487127 citedByCount "66" @default.
• W2092487127 countsByYear W20924871272012 @default.
• W2092487127 countsByYear W20924871272013 @default.
• W2092487127 countsByYear W20924871272014 @default.
• W2092487127 countsByYear W20924871272015 @default.
• W2092487127 countsByYear W20924871272016 @default.
• W2092487127 countsByYear W20924871272017 @default.
• W2092487127 countsByYear W20924871272018 @default.
• W2092487127 countsByYear W20924871272019 @default.
• W2092487127 countsByYear W20924871272020 @default.
• W2092487127 countsByYear W20924871272021 @default.
• W2092487127 countsByYear W20924871272022 @default.
• W2092487127 crossrefType "journal-article" @default.
• W2092487127 hasAuthorship W2092487127A5067161403 @default.
• W2092487127 hasBestOaLocation W20924871272 @default.
• W2092487127 hasConcept C118552586 @default.
• W2092487127 hasConcept C126322002 @default.
• W2092487127 hasConcept C139719470 @default.
• W2092487127 hasConcept C142724271 @default.
• W2092487127 hasConcept C150966472 @default.
• W2092487127 hasConcept C151730666 @default.
• W2092487127 hasConcept C15744967 @default.
• W2092487127 hasConcept C162324750 @default.
• W2092487127 hasConcept C170493617 @default.
• W2092487127 hasConcept C185592680 @default.
• W2092487127 hasConcept C204787440 @default.
• W2092487127 hasConcept C27081682 @default.
• W2092487127 hasConcept C2776867660 @default.
• W2092487127 hasConcept C2777669559 @default.
• W2092487127 hasConcept C2777972943 @default.
• W2092487127 hasConcept C2779177272 @default.
• W2092487127 hasConcept C2779343474 @default.
• W2092487127 hasConcept C2779436514 @default.
• W2092487127 hasConcept C2779442783 @default.
• W2092487127 hasConcept C2780051608 @default.
• W2092487127 hasConcept C2780733359 @default.
• W2092487127 hasConcept C2781063702 @default.
• W2092487127 hasConcept C2781066024 @default.

• next